Skip Nav Destination
First Edition
Research Article August 16 2024
Deletions in the MAL gene result in loss of Mal protein, defining the rare inherited AnWj-negative blood group phenotype
Review Article July 26 2024
Treatment of Relapsed/Refractory MCL
Research Article July 24 2024
JAK2/mTOR Inhibition Fails to Prevent Acute GVHD Despite Reduced Th1/Th17 cells: Final Phase II Trial Results
Joseph A Pidala,Shernan G Holtan,Kelly Walton,Jongphil Kim,Biwei Cao,Hany Elmariah,Asmita Mishra,Nelli Bejanyan,Taiga Nishihori,Farhad Khimani,Lia E Perez,Rawan G Faramand,Marco L. Davila,Shannon McSain,Jordan Pleskow,Jeffrey Baron,Claudio Anasetti,Carlos M Moran Segura,Daniel J Weisdorf,Bruce R Blazar,Jeffrey S. Miller,Veronika Bachanova,Najla El Jurdi,Brian C Betts
Research Article July 24 2024
Diagnostic Guidelines for Familial Hemophagocytic Lymphohistiocytosis Revisited
Review Article July 24 2024
How I treat post-immunotherapy relapsed B-ALL
Review Article July 8 2024
How I Treat: Differentiation Therapy in Acute Myeloid Leukemia
Review Article June 28 2024
How I treat iron overload in adult myelodysplastic syndrome
Review Article June 21 2024
How I Treat Infant Acute Lymphoblastic Leukemia
Review Article June 7 2024
How I manage major hemorrhage
Review Article May 10 2024
How I Treat Challenging Transfusion Cases in Sickle Cell Disease
Review Article May 10 2024
How I manage iron overload in the hemopoietic cell transplantation setting
Review Article April 18 2024
Primary Large B-cell Lymphomas of Immune-Privileged Sites
Review Article March 18 2024
Frontline Treatment of Mantle Cell Lymphoma
Retraction March 17 2024
2023 Annual Meeting Abstract 178791 retraction
Review Article December 24 2023
Peripheral T-cell lymphoma: Are all patients high-risk?
Review Article November 3 2023
DLBCL: Who is high risk and how should treatment be optimized?
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals
